Boehringer Ingelheim initiates Phase IIa study of compound acquired fro
Boehringer Ingelheim commences Phase II program of investigational drug cand...
2017-08-29
文传商讯
Takeda Completes Enrollment of More Than 20,000 Children and Adolescent
etravalent Immunization against Dengue Efficacy Study (TIDES) trial evaluate...
2017-04-13
文传商讯
Boehringer Ingelheim bevacizumab biosimilar candidate demonstrates bioe
Phase I study shows bioequivalence between BI 695502 and Avastin® (bevac...
2016-11-18
文传商讯
Oral Ozanimod Efficacy and Safety Results from Phase 2 TOUCHSTONE Exten
Open-label extension of TOUCHSTONE study of ozanimod showed continued sympto...
2016-10-18
文传商讯
Celgene to Present New Data on Investigational Compounds at UEGW and AC
Exploratory phase 1b study interim data assessing the effects of oral GED-03...
2016-10-17
文传商讯
Takeda Initiates Global Phase 3 Clinical Trial (TIDES) of Dengue Vaccin
Study to evaluate vaccine protection against all four strains of dengue viru...
2016-09-09
文传商讯
AbbVie and Boehringer Ingelheim announce global collaboration on promis
AbbVie and Boehringer Ingelheim will share responsibility for future clinica...
2016-03-08
文传商讯
